{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T17:31:58Z","timestamp":1767720718998,"version":"build-2065373602"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China, Youth fund project","award":["82201354"],"award-info":[{"award-number":["82201354"]}]},{"name":"Health Research Project of Hunan Provincial Health Commission","award":["W20243001"],"award-info":[{"award-number":["W20243001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04449-1","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:46:05Z","timestamp":1760525165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and radiological characteristics of adult-onset X-linked adrenoleukodystrophy: a Chinese cohort study and review of the literature"],"prefix":"10.1186","volume":"25","author":[{"given":"Han","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenchu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuling","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hainan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"10","key":"4449_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrendo.2016.90","volume":"12","author":"S Kemp","year":"2016","unstructured":"Kemp S, Huffnagel IC, Linthorst GE, Wanders RJ, Engelen M. Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history. Nat Rev Endocrinol. 2016;12(10):606\u201315. https:\/\/doi.org\/10.1038\/nrendo.2016.90.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"4449_CR2","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1750-3639.2010.00391.x","volume":"20","author":"S Kemp","year":"2010","unstructured":"Kemp S, Wanders R. Biochemical aspects of X-linked adrenoleukodystrophy. Brain Pathol. 2010;20(4):831\u20137. https:\/\/doi.org\/10.1111\/j.1750-3639.2010.00391.x.","journal-title":"Brain Pathol"},{"key":"4449_CR3","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s10072-021-05859-y","volume":"43 5","author":"J Chenhui Mao","year":"2022","unstructured":"Chenhui Mao J, Li X, Huang J, Wang S, Chu Y, Zhang, et al. Typical and atypical phenotype and neuroimaging of X\u2013linked adrenoleukodystrophy in a Chinese cohort. Neurol Sci. 2022;43 5:3255\u201363. https:\/\/doi.org\/10.1007\/s10072-021-05859-y.","journal-title":"Neurol Sci"},{"key":"4449_CR4","doi-asserted-by":"publisher","first-page":"e731","DOI":"10.1212\/WNL.0000000000007958","volume":"93 7","author":"A LWC","year":"2019","unstructured":"LWC A, AYY C, Teaching Neuroimages VCTM. X-linked adrenoleukodystrophy: spinocerebellar Vatiant. Neurology. 2019;93 7:e731\u20132. https:\/\/doi.org\/10.1212\/WNL.0000000000007958.","journal-title":"Neurology"},{"issue":"1","key":"4449_CR5","doi-asserted-by":"publisher","first-page":"15093","DOI":"10.1038\/s41598-020-71248-8","volume":"10","author":"TW Rattay","year":"2020","unstructured":"Rattay TW, Rautenberg M, S\u00f6hn AS, Hengel H, Trasch\u00fctz A, R\u00f6ben B, et al. Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-adrenoleukodystrophy. Sci Rep. 2020;10(1):15093. https:\/\/doi.org\/10.1038\/s41598-020-71248-8.","journal-title":"Sci Rep"},{"key":"4449_CR6","doi-asserted-by":"publisher","unstructured":"Chen T, Chen X, Zhang S, Zhu J, Tang B, Wang A, et al. Genomics Proteom Bioinf. 2021;19(4):578\u201383. https:\/\/doi.org\/10.1016\/j.gpb.2021.08.001. The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types.","DOI":"10.1016\/j.gpb.2021.08.001"},{"key":"4449_CR7","doi-asserted-by":"publisher","first-page":"D27","DOI":"10.1093\/nar\/gkab951","volume":"50 D1","author":"C-NM Partners","year":"2021","unstructured":"Partners C-NM, Database Resources of the National Genomics Data Center. China National center for bioinformation in 2022. Nucleic Acids Res. 2021;50 D1:D27\u201338. https:\/\/doi.org\/10.1093\/nar\/gkab951.","journal-title":"Nucleic Acids Res"},{"issue":"24","key":"4449_CR8","first-page":"3131","volume":"294","author":"M Hw","year":"2005","unstructured":"Hw M, Gv R. Adrenoleukodystrophy: new approaches to a neurodegenerative disease. JAMA Neurol. 2005;294(24):3131\u20134.","journal-title":"JAMA Neurol"},{"key":"4449_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/s0002-9343(89)80844-7","volume":"87 4","author":"P PK","year":"1989","unstructured":"PK P. Adult-onset adrenoleukodystrophy manifesting as dementia. Am J Med. 1989;87 4:481\u20133. https:\/\/doi.org\/10.1016\/s0002-9343(89)80844-7.","journal-title":"Am J Med"},{"key":"4449_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X17741009","volume":"5","author":"D Shamim","year":"2017","unstructured":"Shamim D, Alleyne K. X-linked adult-onset adrenoleukodystrophy: psychiatric and neurological manifestations. SAGE Open Med Case Rep. 2017;5:2050313x17741009. https:\/\/doi.org\/10.1177\/2050313X17741009.","journal-title":"SAGE Open Med Case Rep"},{"key":"4449_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pediatrneurol.2015.08.005","volume":"54","author":"JSA Magalh\u00e3es","year":"2016","unstructured":"Magalh\u00e3es JSA, Siqueira ES, Masruha MR. Extensive asymmetric pattern in cerebral X-linked adrenoleukodystrophy. Pediatr Neurol. 2016;54:99. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2015.08.005.","journal-title":"Pediatr Neurol"},{"key":"4449_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2017.08.018","volume":"381","author":"T Tsuboi","year":"2017","unstructured":"Tsuboi T, Tanaka Y, Yoshida Y, Nakamura T, Shimozawa N, Katsuno M. Highly asymmetric and subacutely progressive motor weakness with unilateral T2-weighted high intensities along the pyramidal tract in the brainstem in adrenomyeloneuropathy. J Neurol Sci. 2017;381:107\u20139. https:\/\/doi.org\/10.1016\/j.jns.2017.08.018.","journal-title":"J Neurol Sci"},{"issue":"1","key":"4449_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1065","volume":"8","author":"W-J Luo","year":"2020","unstructured":"Luo W-J, Wei Q, Dong H-L, Yan Y-T, Chen M-J, Li H-F. Spastic paraplegia as the predominant phenotype in a cohort of Chinese patients with adrenoleukodystrophy. Mol Genet Genomic Med. 2020;8(1):e1065. https:\/\/doi.org\/10.1002\/mgg3.1065.","journal-title":"Mol Genet Genomic Med"},{"issue":"5","key":"4449_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.braindev.2004.09.008","volume":"27","author":"Y Suzuki","year":"2005","unstructured":"Suzuki Y, Takemoto Y, Shimozawa N, Imanaka T, Kato S, Furuya H, et al. Natural history of X-linked adrenoleukodystrophy in Japan. Brain Dev. 2005;27(5):353\u20137. https:\/\/doi.org\/10.1016\/j.braindev.2004.09.008.","journal-title":"Brain Dev"},{"issue":"5","key":"4449_CR15","doi-asserted-by":"publisher","first-page":"e0177296","DOI":"10.1371\/journal.pone.0177296","volume":"12","author":"Y-H Chen","year":"2017","unstructured":"Chen Y-H, Lee Y-C, Tsai Y-S, Guo Y-C, Hsiao C-T, Tsai P-C, et al. Unmasking adrenoleukodystrophy in a cohort of cerebellar ataxia. PLoS ONE. 2017;12(5):e0177296. https:\/\/doi.org\/10.1371\/journal.pone.0177296. eCollection 2017.","journal-title":"PLoS ONE"},{"issue":"5","key":"4449_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1590\/0004-282X-ANP-2020-0294","volume":"79","author":"MPMd Moraes","year":"2021","unstructured":"Moraes MPMd, Rosa ABR, Jaques CS, Marussi VHR, Pedroso JL, Barsottini OG. X-linked adrenoleukodystrophy presenting as progressive ataxia and pure cerebellar involvement. Arq Neuropsiquiatr. 2021;79(5):463\u20134. https:\/\/doi.org\/10.1590\/0004-282X-ANP-2020-0294.","journal-title":"Arq Neuropsiquiatr"},{"issue":"2","key":"4449_CR17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1210\/jcem.81.2.8636252","volume":"81","author":"S Laureti","year":"1996","unstructured":"Laureti S, Casucci G, Santeusanio F, Angeletti G, Aubourg P, Brunetti P. X-linked adrenoleukodystrophy is a frequent cause of idiopathic addison\u2019s disease in young adult male patients. J Clin Endocrinol Metab. 1996;81(2):470\u20134. https:\/\/doi.org\/10.1210\/jcem.81.2.8636252.","journal-title":"J Clin Endocrinol Metab"},{"key":"4449_CR18","doi-asserted-by":"publisher","unstructured":"Huffnagel IC, Laheji FK, Aziz-Bose R, Tritos NA, Marino GE et al. The Natural History of Adrenal Insufficiency in X-Linked Adrenoleukodystrophy: An International Collaboration. J Clin Endocrinol Metab. 2019;104 1:118\u2009\u2013\u200926; https:\/\/doi.org\/10.1210\/jc.2018-01307","DOI":"10.1210\/jc.2018-01307"},{"issue":"2","key":"4449_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijns8020029","volume":"8","author":"CV Baker","year":"2022","unstructured":"Baker CV, Keller AC, Lutz R, Eveans K, Baumert K, DiPerna JC, et al. Newborn screening for X-linked adrenoleukodystrophy in Nebraska: initial experiences and challenges. Int J Neonatal Screen. 2022;8(2):29. https:\/\/doi.org\/10.3390\/ijns8020029.","journal-title":"Int J Neonatal Screen"},{"key":"4449_CR20","doi-asserted-by":"publisher","unstructured":"Jaspers YRJ, Ferdinandusse S, Dijkstra IME, Barendsen RW, Lenthe Hv, Kulik W, et al. Comparison of the diagnostic performance of C26:0-lysophosphatidylcholine and very long-chain fatty acids analysis for peroxisomal disorders. Front Cell Dev Biol. 2020;8:690. https:\/\/doi.org\/10.3389\/fcell.2020.00690. (eCollection 2020).","DOI":"10.3389\/fcell.2020.00690"},{"key":"4449_CR21","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1212\/WNL.0000000000201374","volume":"99 21","author":"M Engelen","year":"2022","unstructured":"Engelen M, Ballegoij WJCv, Mallack EJ, Haren KPV, K\u00f6hler W, Salsano E, et al. International recommendations for the diagnosis and management of patients with adrenoleukodystrophy: A Consensus-Based approach. Neurology. 2022;99 21:940\u201351. https:\/\/doi.org\/10.1212\/WNL.0000000000201374.","journal-title":"Neurology"},{"key":"4449_CR22","doi-asserted-by":"publisher","first-page":"100516","DOI":"10.1016\/j.jlr.2024.100516","volume":"65 3","author":"B Morales-Romero","year":"2024","unstructured":"Morales-Romero B, Aledo-Castillo JMGd, Sierra CF, Carreira CM, Bonet CZ, Bonifacio RF, et al. Plasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal \u03b2-oxidation disorders. J Lipid Res. 2024;65 3:100516. https:\/\/doi.org\/10.1016\/j.jlr.2024.100516.","journal-title":"J Lipid Res"},{"issue":"9","key":"4449_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238796","volume":"15","author":"TJ Stradomska","year":"2020","unstructured":"Stradomska TJ, Syczewska M, Jamroz E, Pleskaczy\u0144ska A, Kruczek P, Ciara E, et al. Serum very long-chain fatty acids (VLCFA) levels as predictive biomarkers of diseases severity and probability of survival in peroxisomal disorders. PLoS ONE. 2020;15(9):e0238796. https:\/\/doi.org\/10.1371\/journal.pone.0238796.","journal-title":"PLoS ONE"},{"key":"4449_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/cells11020283","volume":"11 2","author":"EJ Mallack","year":"2022","unstructured":"Mallack EJ, Gao K, Engelen M, Kemp t. Structure and function of the ABCD1 variant database: 20 Years, 940 pathogenic variants, and 3400 cases of adrenoleukodystrophy. Cells. 2022;11 2:283. https:\/\/doi.org\/10.3390\/cells11020283.","journal-title":"Cells"},{"key":"4449_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-51","author":"M Engelen","year":"2012","unstructured":"Engelen M, Kemp S, Visser Md G, BMv, Wanders RJA, Aubourg P, et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis. 2012. https:\/\/doi.org\/10.1186\/1750-1172-7-51.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4449_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcz048","volume":"2","author":"T Matsukawa","year":"2020","unstructured":"Matsukawa T, Yamamoto T, Honda A, Toya T, Ishiura H, Mitsui J, et al. Clinical efficacy of haematopoietic stem cell transplantation for adult adrenoleukodystrophy. Brain Commun. 2020;2(1):fcz048. https:\/\/doi.org\/10.1093\/braincomms\/fcz048.","journal-title":"Brain Commun"},{"issue":"1","key":"4449_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/MED.0000000000000782","volume":"30","author":"J Gujral","year":"2023","unstructured":"Gujral J, Sethuram S. An update on the diagnosis and treatment of adrenoleukodystrophy. Curr Opin Endocrinol Diabetes Obes. 2023;30(1):44\u201351. https:\/\/doi.org\/10.1097\/MED.0000000000000782.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"9","key":"4449_CR28","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.bbadis.2012.03.012","volume":"1822","author":"S Kemp","year":"2012","unstructured":"Kemp S, Berger J, Aubourg P. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects. Biochim Biophys Acta. 2012;1822(9):1465\u201374.","journal-title":"Biochim Biophys Acta"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04449-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04449-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04449-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:46:05Z","timestamp":1760525165000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04449-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4449"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04449-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Ethics Committee of Second Xiangya Hospital and was conducted in compliance with the Declaration of Helsinki. Informed consent was obtained from all participants. For participants experiencing cognitive decline, written informed consent was secured from their family members.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed written consent for the publication of identifying data and images in the case report was secured from all patients. For the patient under the age of 18, written consent was obtained from his parents or legal guardians. Additionally, written informed consent for publication was acquired from the families of the participants with cognitive decline.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"428"}}